Atricure, INC Form 4 insider transactions

Deborah Lee Yount, Chief Human Resources Officer at AtriCure, Inc., reports acquisition of shares through a restricted stock award and disposition of shares to cover tax obligations.

AtriCure's CEO, Michael Carrel, reports acquisition and disposal of company stock, including shares from restricted stock and performance share awards.

AtriCure's Chief Financial Officer, Angela Wirick, reported the acquisition and disposal of company stock and the exercise of stock options on March 1, 2024.

AtriCure's Chief Legal Officer, Karl S. Dahlquist, reports acquiring shares through a restricted stock award and the vesting of a performance share award.

AtriCure's Chief Operating Officer, Douglas J. Seith, reports acquisition and disposal of company stock, including shares from restricted stock and performance share awards.

AtriCure's Chief Scientific Officer, Vinayak Doraiswamy, reports acquisition and disposal of company stock related to restricted stock and performance share awards.

Justin J. Noznesky, Chief Marketing & Strategy Officer at AtriCure, Inc., reports acquisition and disposal of company stock.

AtriCure's Chief Technical Officer, Salvatore Privitera, reports acquisition and disposal of company stock related to restricted stock and performance share awards.

Director Robert S. White exercised non-qualified stock options to acquire 10,000 shares of AtriCure, Inc. common stock at a price of $15.96 on February 23, 2024.